CDKL5 and Aicardi-Goutières syndrome: 41 The development of disease-specific outcomes measures has been completed with some neurogenetic conditions such as CDKL5 deficiency disorder and Aicardi Goutières syndrome to avoid floor effects, which could mask potential changes as the result of an intervention.46,47